​

Ernexa Therapeutics Ownership | Who Owns Ernexa Therapeutics?

OverviewFinancialsChart

Ernexa Therapeutics Ownership Summary

Ernexa Therapeutics is owned by 3.00% institutional investors, 29.82% insiders, and 67.17% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of ERNA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.49% of its assets in Ernexa Therapeutics shares.

ERNA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockErnexa Therapeutics3.00%29.82%67.17%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management---
Vanguard personalized indexing management---
Cypress point wealth management---
Two sigma securities---
Eversource wealth advisors---
Montag a & associates---
Assetmark---
Jane street group---
Ci private wealth---
Activest wealth management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Vanguard personalized indexing management---
Cypress point wealth management---
Two sigma securities---
Eversource wealth advisors---
Montag a & associates---
Assetmark---
Jane street group---
Ci private wealth---
Activest wealth management---

Top Buyers

HolderShares% AssetsChange
Activest wealth management---3.00
Sbi securities---6.00
Montag a & associates---8.00
Bnp paribas arbitrage, snc---10.00
Group one trading---19.00

Top Sellers

HolderShares% AssetsChange
Bleichroeder lp---2.00M
Dauntless investment group---612.44K
Ci private wealth---438.09K
Geode capital management---244.45K
Two sigma securities---229.34K

Sold Out

HolderChange
Activest wealth management-3.00
Sbi securities-6.00
Montag a & associates-8.00
Bnp paribas arbitrage, snc-10.00
Group one trading-19.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20269-52.63%35,525-99.01%30.92%1-92.31%8-
Mar 31, 202619-3,574,358-18-19---
Mar 31, 2025268.33%1,488,38549.68%25.25%129.09%525.00%
Dec 31, 20242420.00%994,39339.80%74.22%11120.00%433.33%
Sep 30, 2024205.26%711,29982.35%1325.29%5-3200.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr5.68K0.49%-
Fidelity Extended Market Index5.57K0.48%-
Fidelity Series Total Market Index1.60K0.14%-812.00
NT Ext Equity Mkt Index Fund - NL1.52K0.13%1.52K
NT Ext Equity Mkt Idx Fd - DC - NL - T21.10K0.09%1.10K
Cinvest Azero Global FI537.000.05%-
BlackRock Extended Equity Market K2.28K0.04%-1.00
Fidelity Nasdaq Composite Index1.17K0.02%-
Vanguard Total Stock Mkt Idx Inv12.09K0.02%-
SSgA U.S. Extended Market Index Class I766.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 10, 2026Cherington Charles-Buy$2.72M
Feb 10, 2026Cherington Charles-Buy$2.00M
Jun 09, 2025Cherington Charles-Buy$2.22M
Sep 24, 2024Cherington Charles-Buy$2.24M
Sep 24, 2024Cherington Charles-Buy-

Insider Transactions Trends

DateBuySell
2026 Q3--
2026 Q12-
2025 Q22-
2025 Q1--
2024 Q473

ERNA Ownership FAQ

Who Owns Ernexa Therapeutics?

Ernexa Therapeutics shareholders are primarily institutional investors at 3.00%, followed by 29.82% insiders and 67.18% retail investors. The average institutional ownership in Ernexa Therapeutics's industry, Biotech Stocks , is 380.48%, which Ernexa Therapeutics falls below.

Who owns the most shares of Ernexa Therapeutics?

Ernexa Therapeutics’s largest shareholders are Geode capital management (0 shares, 0%), Vanguard personalized indexing management (0 shares, 0%), and Cypress point wealth management (0 shares, 0%). Together, they hold 0% of Ernexa Therapeutics’s total shares outstanding.

Does Blackrock own Ernexa Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Ernexa Therapeutics.

Who is Ernexa Therapeutics’s biggest shareholder by percentage of total assets invested?

Geode capital management is Ernexa Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Ernexa Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Ernexa Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Ernexa Therapeutics shares, with 0.49% of its total shares outstanding invested in 5.68K Ernexa Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools